which one of the following is true:
**Core Concept**
The question is testing the understanding of the pathophysiology of **tachyarrhythmias**, specifically the role of **beta-adrenergic receptors** in modulating heart rate. The correct answer is related to the **mechanism of beta-blockers** in treating these conditions.
**Why the Correct Answer is Right**
Beta-blockers, such as propranolol, are a class of medications used to treat tachyarrhythmias by blocking the action of beta-adrenergic receptors in the heart. These receptors, primarily beta-1 receptors, stimulate the sinoatrial (SA) node, increasing heart rate. By blocking these receptors, beta-blockers decrease the heart rate, reducing the severity of tachyarrhythmias. This is achieved through the inhibition of **adenylyl cyclase**, a key enzyme in the **cAMP signaling pathway**, which decreases the intracellular concentration of cyclic adenosine monophosphate (cAMP), a secondary messenger that triggers the **L-type calcium channel** opening, leading to increased heart rate.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as beta-blockers do not work by increasing the heart rate. In fact, they decrease heart rate by blocking beta-adrenergic receptors.
**Option B:** This option is incorrect as calcium channel blockers, such as verapamil, work by blocking L-type calcium channels, not beta-adrenergic receptors. While they can also decrease heart rate, their mechanism is distinct from beta-blockers.
**Option C:** This option is incorrect as digoxin, a cardiac glycoside, works by inhibiting the **Na+/K+-ATPase pump**, not beta-adrenergic receptors. It increases the force of contraction, but does not decrease heart rate through the same mechanism as beta-blockers.
**Clinical Pearl / High-Yield Fact**
When treating tachyarrhythmias, it's essential to understand the mechanism of action of beta-blockers, as they can be effective in reducing heart rate and alleviating symptoms. However, it's also crucial to consider the potential side effects of beta-blockers, such as **bronchospasm** and **hypotension**, particularly in patients with **asthma** or **chronic obstructive pulmonary disease (COPD)**.
**Correct Answer:** B. Beta-blockers work by blocking beta-adrenergic receptors in the heart, decreasing heart rate and alleviating symptoms of tachyarrhythmias.